Indian Shares

An illustration of the skill set within the Indian pharmaceutical industry is shown by the reported ability of Cipla to produce in large scale volumes a generic bird flu vaccine called Antiflu. Roche have the patent for Tamiflu but grey areas within India law have resulted in Cipla pressing ahead with their own version of Tamiflu called Antiflu. This generic bird flu vaccine is already being mass produced and stored by Cipla, ready for distribution should the Indian government give such permission.

 Cipla was probably previously best known for producing anti-aids drugs for sale within India.